Financhill
Back

InfuSystems Holdings Quote, Financials, Valuation and Earnings

InfuSystems Holdings Price Quote

$6.22
+0.09 (+1.47%)
(Updated: October 31, 2024 at 6:45 PM ET)

InfuSystems Holdings Key Stats

Sell
42
InfuSystems Holdings (INFU) is a Sell

Day range:
$6.13 - $6.31
52-week range:
$5.74 - $10.99
Dividend yield:
0%
P/E ratio:
158.00
P/S ratio:
1.06
P/B ratio:
2.52%

Volume:
21.7K
Avg. volume:
87.6K
1-year change:
-37.83%
Market cap:
$134.7M
Revenue:
$125.8M
EPS:
$0.01

How Much Does InfuSystems Holdings Make?

Is InfuSystems Holdings Growing As A Company?

  • What Is InfuSystems Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is InfuSystems Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.5%

InfuSystems Holdings Stock Price Performance

What Is InfuSystems Holdings 52-Week High & Low?

InfuSystems Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy InfuSystems Holdings?

Is InfuSystems Holdings Cash Flow Positive?

  • What Is INFU Cash Flow From Operations?
    Cash flow from operations (TTM) is $11.6M
  • What Is InfuSystems Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$3.1M
  • What Is InfuSystems Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$8.5M

InfuSystems Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    INFU return on invested capital is 0.43%
  • What Is InfuSystems Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 0.35%
  • What Is INFU Return On Equity?
    ROE is a measure of profitability and is 0.71%

InfuSystems Holdings Earnings Date & Stock Price

InfuSystems Holdings Competitors

  • Who Are InfuSystems Holdings's Competitors?
    Below is a list of companies who compete with InfuSystems Holdings or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Tactile Systems Technology Inc (TCMD)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

InfuSystems Holdings Dividend Yield

InfuSystems Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 50% 0%
Revenue: 6.19% 1.6%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.88
Upside from Last Price: 126.35%

Major Shareholders

  • How many INFU shares are owned by institutional investors?
    20.3M INFU shares are owned by institutional investors
  • How many INFU shares are owned by insiders?
    4.7M INFU shares are owned by insiders